Finance News Network Interview, 12. Nov. 2018, Immutep Limited (ASX:IMM) Executive Director and CEO, Marc Voigt provides an update on the company's clinical trials, collaboration with large pharma and key milestones.
Your Money - Interview with Marc Voigt (Executive Director and CEO), 31. Oct. 2018
Finance News Network - Interview with Marc Voigt (Executive Director and CEO), 06. Sept. 2018
Brand movie - bringing new hope to patients
FNN – Interview with Immutep
Sky Business News - Interview with Marc Voigt (Executive Director and CEO), 30. April 18
Interview with Frédéric Triebel /CSO & CMO) & Marc Voigt (Executive Director and CEO)
CNBC - Interview with Marc Voigt (Executive Director and CEO)
Mode of Action of eftilagimod alpha (“IMP321”)
Sky Business News - Interview with Marc Voigt (Executive Director and CEO), 25. Nov. 15
The Business - Interview with Lucy Turnbull
Sky Business News - Interview with Marc Voigt (Executive Director and CEO), 16. May 2014
